We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
-$142M
Cap. Flow %
-13.41%
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.54M
2
IAUM icon
iShares Gold Trust Micro
IAUM
+$4.59M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.58M
4
INTU icon
Intuit
INTU
+$3.2M
5
TMUS icon
T-Mobile US
TMUS
+$2.41M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$10M
3
NVDA icon
NVIDIA
NVDA
+$9.7M
4
AMZN icon
Amazon
AMZN
+$7.99M
5
AVGO icon
Broadcom
AVGO
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCCC icon
451
C4 Therapeutics
CCCC
$480M
$20.4K ﹤0.01%
14,261
+22
+0.2% +$32
EW icon
452
Edwards Lifesciences
EW
$53.6B
$20K ﹤0.01%
256
– –
CLYM
453
Climb Bio
CLYM
$827M
$16.8K ﹤0.01%
13,572
+88
+0.7% +$110
MGNX icon
454
MacroGenics
MGNX
$256M
$15.3K ﹤0.01%
12,671
+82
+0.7% +$119
TCRX icon
455
TScan Therapeutics
TCRX
$50.5M
$15.2K ﹤0.01%
10,507
+660
+7% +$954
RGEN icon
456
Repligen
RGEN
$9.35B
$14.3K ﹤0.01%
115
– –
PLRX icon
457
Pliant Therapeutics
PLRX
$66.3M
$14.3K ﹤0.01%
12,329
+123
+1% +$174
ILMN icon
458
Illumina
ILMN
$29.1B
$13.9K ﹤0.01%
146
– –
PYXS icon
459
Pyxis Oncology
PYXS
$201M
$13.7K ﹤0.01%
12,442
+514
+4% +$579
BMEA icon
460
Biomea Fusion
BMEA
$92.8M
$13.6K ﹤0.01%
7,546
+277
+4% +$534
CRL icon
461
Charles River Laboratories
CRL
$13.6B
$13.5K ﹤0.01%
89
– –
GSK icon
462
GSK
GSK
$101B
$13.1K ﹤0.01%
338
– –
QTRX icon
463
Quanterix
QTRX
$139M
$12.6K ﹤0.01%
1,894
– –
STRO icon
464
Sutro Biopharma
STRO
$353M
$12.1K ﹤0.01%
1,696
+42
+3% +$343
SDY icon
465
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$10.2K ﹤0.01%
75
– –
APLT
466
DELISTED
Applied Therapeutics
APLT
$8.85K ﹤0.01%
28,435
+5,096
+22% +$1.97K
IGMS
467
DELISTED
IGM Biosciences
IGMS
$7.81K ﹤0.01%
6,975
+140
+2% +$171
ACRV icon
468
Acrivon Therapeutics
ACRV
$73.6M
$7.5K ﹤0.01%
6,298
+53
+0.8% +$73
MRSN
469
DELISTED
Mersana Therapeutics
MRSN
$7.41K ﹤0.01%
1,001
+10
+1% +$88
ARTV
470
Artiva Biotherapeutics
ARTV
$564M
$7.39K ﹤0.01%
4,893
+21
+0.4% +$44
PEPG icon
471
PepGen
PEPG
$201M
$7.29K ﹤0.01%
6,572
+14
+0.2% +$20
OKUR
472
OnKure Therapeutics
OKUR
$159M
$6.16K ﹤0.01%
2,576
+38
+1% +$100
WOLF icon
473
Wolfspeed
WOLF
$1.65B
$3.99K ﹤0.01%
10,000
– –
QTTB icon
474
Q32 Bio
QTTB
$458M
$3.65K ﹤0.01%
2,450
+7
+0.3% +$12
HSY icon
475
Hershey
HSY
$37B
$1.66K ﹤0.01%
10
– –
17 18
19
20 21

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.

  • China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
  • China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
  • China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
  • China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
  • China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
  • China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.